Variant report

Variant	nsv469942
Chromosome Location	chr11:23677246-23723766
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:5)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:23712261..23714812-chr11:23726962..23729358,2	K562	blood:
2	chr11:23713225..23715504-chr11:23720246..23721899,2	K562	blood:
3	chr11:23713225..23715504-chr11:23720246..23721899,2	K562	blood:
4	chr11:23711821..23714725-chr11:23720399..23722381,2	K562	blood:
5	chr11:23711821..23714725-chr11:23720399..23722381,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LUZP2-5	chr11:23683281-23683759	NONHSAT018424
2	lnc-LUZP2-4	chr11:23697000-23697314	NONHSAT018425
3	lnc-LUZP2-5	chr11:23697639-23701053	NONHSAT018424
4	lnc-LUZP2-4	chr11:23695358-23696510	NONHSAT018425

No data

Extended variants
information (count: 1168 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:1168 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7126196	chr11:23683283-23683284	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs190322193	chr11:23683285-23683286	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs182092553	chr11:23683288-23683289	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs540909759	chr11:23683290-23683291	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs138065089	chr11:23683295-23683296	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs577734488	chr11:23683335-23683336	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs185349957	chr11:23683352-23683353	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
8	rs562800222	chr11:23683358-23683359	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
9	rs531739986	chr11:23683403-23683404	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
10	rs190940518	chr11:23683409-23683410	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
11	rs11306109	chr11:23683417-23683418	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
12	rs562048704	chr11:23683418-23683419	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
13	rs184032880	chr11:23683468-23683469	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
14	rs533550629	chr11:23683474-23683475	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
15	rs149033612	chr11:23683498-23683499	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
16	rs143051531	chr11:23683509-23683510	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
17	rs79809890	chr11:23683529-23683530	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
18	rs549854662	chr11:23683552-23683553	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
19	rs2403830	chr11:23683565-23683566	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs535166475	chr11:23683676-23683677	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
21	rs76542444	chr11:23683745-23683746	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
22	rs534976025	chr11:23695386-23695387	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
23	rs541259183	chr11:23695389-23695390	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
24	rs146725690	chr11:23695427-23695428	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
25	rs139455179	chr11:23695462-23695463	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
26	rs144142169	chr11:23695477-23695478	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
27	rs543077164	chr11:23695482-23695483	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
28	rs563149326	chr11:23695493-23695494	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
29	rs4567460	chr11:23695501-23695502	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs548701127	chr11:23695505-23695506	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
31	rs571284162	chr11:23695525-23695526	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
32	rs186129827	chr11:23695666-23695667	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
33	rs7946184	chr11:23695668-23695669	Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs551630630	chr11:23695679-23695680	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
35	rs557188157	chr11:23695691-23695692	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
36	rs144908805	chr11:23695706-23695707	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs377221911	chr11:23695737-23695738	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
38	rs189403259	chr11:23695757-23695758	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
39	rs181366771	chr11:23695765-23695766	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
40	rs73435812	chr11:23695779-23695780	Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs186782945	chr11:23695788-23695789	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
42	rs149025822	chr11:23695824-23695825	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
43	rs541294836	chr11:23695842-23695843	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs543257896	chr11:23695845-23695846	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
45	rs555536378	chr11:23695868-23695869	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs557943915	chr11:23695883-23695884	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs577776587	chr11:23695895-23695896	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs143087439	chr11:23695898-23695899	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs574026628	chr11:23695911-23695912	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs563447387	chr11:23695935-23695936	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Myelofibrosis	22110671	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:23695600-23696000	Enhancers	Fetal Intestine Large	intestine
2	chr11:23699800-23702800	Enhancers	Dnd41	blood
3	chr11:23700600-23700800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr11:23700600-23700800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr11:23700800-23702600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr11:23701800-23702000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr11:23702000-23702800	Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
8	chr11:23702200-23702400	Bivalent/Poised TSS	HepG2	liver
9	chr11:23702400-23702800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
10	chr11:23702400-23702800	Bivalent Enhancer	HepG2	liver
11	chr11:23702600-23702800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr11:23702800-23704400	Weak transcription	Dnd41	blood
13	chr11:23704400-23708000	Enhancers	Dnd41	blood
14	chr11:23705800-23706200	Enhancers	Brain Germinal Matrix	brain
15	chr11:23706000-23706600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
16	chr11:23706600-23709400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr11:23706800-23707200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
18	chr11:23708000-23709200	Weak transcription	Dnd41	blood
19	chr11:23709200-23712800	Enhancers	Dnd41	blood
20	chr11:23709400-23711400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr11:23710200-23710800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr11:23710200-23710800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr11:23710200-23710800	Enhancers	HUVEC	blood vessel
24	chr11:23710400-23710600	Enhancers	HUES64 Cell Line	embryonic stem cell
25	chr11:23710600-23711600	Weak transcription	HUES64 Cell Line	embryonic stem cell
26	chr11:23711600-23711800	Enhancers	HUES64 Cell Line	embryonic stem cell
27	chr11:23711600-23712000	Enhancers	HUES6 Cell Line	embryonic stem cell
28	chr11:23711600-23712000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
29	chr11:23711600-23712200	Enhancers	iPS-20b Cell Line	embryonic stem cell
30	chr11:23711600-23712400	Enhancers	HUES48 Cell Line	embryonic stem cell
31	chr11:23711800-23712400	Enhancers	iPS-18 Cell Line	embryonic stem cell
32	chr11:23711800-23713800	Weak transcription	HUES64 Cell Line	embryonic stem cell
33	chr11:23712000-23712400	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr11:23712000-23714000	Weak transcription	HUES6 Cell Line	embryonic stem cell
35	chr11:23712200-23713800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
36	chr11:23712400-23713600	Weak transcription	HUES48 Cell Line	embryonic stem cell
37	chr11:23712400-23714000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
38	chr11:23712800-23713200	Weak transcription	Dnd41	blood
39	chr11:23712800-23713600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
40	chr11:23713200-23714400	Enhancers	Dnd41	blood
41	chr11:23713600-23714200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr11:23713600-23714600	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr11:23713600-23714600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr11:23713800-23714600	Enhancers	HUES64 Cell Line	embryonic stem cell
45	chr11:23713800-23714600	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr11:23714000-23714200	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr11:23714000-23714400	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr11:23714000-23714600	Enhancers	HUES6 Cell Line	embryonic stem cell
49	chr11:23714200-23714400	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr11:23714200-23714600	Enhancers	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links